FinancialHospitalsOSN PremiumOSP InsiderRegulatory

Medical-device reprocessing saved providers $470 million last year

JESSICA KIM COHEN  / July 29, 2019

Reprocessing medical devices originally labeled for single use saved hospitals and surgery centers nearly $500 million in 2018, according to survey findings released by an industry trade group Monday.

For hospitals, reprocessing a device after patient use typically involves sending it to a third-party reprocessor, which cleans, sterilizes and repackages the device. Hospitals reprocess a range of single-use devices, ranging from non-invasive items like blood pressure cuffs to invasive surgical instruments.

While some clinicians initially expressed concerns over the safety implications of reusing devices, these largely have been assuaged in the wake of FDA oversight and lack of evidence pointing to any such health risks.

“In the early days we were focused on proving, ‘How do you know it’s safe? How do you know it’s clean?’ ” said Dan Vukelich, president of the Association of Medical Device Reprocessors, the group that released the survey findings. The AMDR represents seven reprocessing companies, including Medline ReNewal, ReNu Medical and Stryker’s Sustainability Solutions.

But that has changed. Last year, an estimated 8,885 hospitals and surgical centers across the U.S., Canada and Europe used reprocessed devices.

Mayo Clinic said it rolled out a program dedicated to purchasing reprocessed devices in 2015 as a sustainability initiative.


[mepr-show if=”rule: 52327″ unauth=”both”]

Utilizing reprocessed medical devices has become second nature to providers and has resulted in proven cost savings. I remember the days when this was new to hospitals and there was certainly hesitation, mostly around safety implications and sterility.

Chris Stewart, chief operating officer


Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button